1. International Conferences on Harmonization, Draft Revised Guidance on Impurities in New Drug Substances. Q3A(R). Federal Register 2000, 65(140), 45085–45090.
2. International Conferences on Harmonization, Draft Revised Guidance on Impurities in New Drug Products. Q3B(R). Federal Register 2000, 65(139), 44791–44797.
3. International Conferences on Harmonization, Impurities – Guidelines for Residual Solvents. Q3C. Federal Register 1997, 62(247), 67377.
4. Chromatographic methods for determining the identity, strength and purity of ranitidine hydrochloride both in the drug substance and its dosage from—an exercise in method selection, development, definition and validation
5. United States Pharmacopeia XXIV, United States Pharmacopeial Convention, Rockville 2000, p. 1463.